| UniProt ID | SYT1_HUMAN | |
|---|---|---|
| UniProt AC | P21579 | |
| Protein Name | Synaptotagmin-1 | |
| Gene Name | SYT1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 422 | |
| Subcellular Localization |
Cytoplasmic vesicle, secretory vesicle membrane Single-pass membrane protein . Cytoplasmic vesicle, secretory vesicle, synaptic vesicle membrane Single-pass membrane protein . Cytoplasmic vesicle, secretory vesicle, chromaffin granule membrane Singl |
|
| Protein Description | May have a regulatory role in the membrane interactions during trafficking of synaptic vesicles at the active zone of the synapse. It binds acidic phospholipids with a specificity that requires the presence of both an acidic head group and a diacyl backbone. A Ca(2+)-dependent interaction between synaptotagmin and putative receptors for activated protein kinase C has also been reported. It can bind to at least three additional proteins in a Ca(2+)-independent manner; these are neurexins, syntaxin and AP2. Plays a role in dendrite formation by melanocytes. [PubMed: 23999003] | |
| Protein Sequence | MVSESHHEALAAPPVTTVATVLPSNATEPASPGEGKEDAFSKLKEKFMNELHKIPLPPWALIAIAIVAVLLVLTCCFCICKKCLFKKKNKKKGKEKGGKNAINMKDVKDLGKTMKDQALKDDDAETGLTDGEEKEEPKEEEKLGKLQYSLDYDFQNNQLLVGIIQAAELPALDMGGTSDPYVKVFLLPDKKKKFETKVHRKTLNPVFNEQFTFKVPYSELGGKTLVMAVYDFDRFSKHDIIGEFKVPMNTVDFGHVTEEWRDLQSAEKEEQEKLGDICFSLRYVPTAGKLTVVILEAKNLKKMDVGGLSDPYVKIHLMQNGKRLKKKKTTIKKNTLNPYYNESFSFEVPFEQIQKVQVVVTVLDYDKIGKNDAIGKVFVGYNSTGAELRHWSDMLANPRRPIAQWHTLQVEEEVDAMLAVKK | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 24 | Phosphorylation | TVATVLPSNATEPAS EEEEECCCCCCCCCC | 34.63 | - | |
| 25 | N-linked_Glycosylation | VATVLPSNATEPASP EEEECCCCCCCCCCC | 49.28 | UniProtKB CARBOHYD | |
| 27 | O-linked_Glycosylation | TVLPSNATEPASPGE EECCCCCCCCCCCCC | 46.91 | OGP | |
| 75 | S-palmitoylation | AVLLVLTCCFCICKK HHHHHHHHHHHHHHH | 1.14 | - | |
| 76 | S-palmitoylation | VLLVLTCCFCICKKC HHHHHHHHHHHHHHH | 2.34 | - | |
| 78 | S-palmitoylation | LVLTCCFCICKKCLF HHHHHHHHHHHHHHH | 1.92 | - | |
| 80 | S-palmitoylation | LTCCFCICKKCLFKK HHHHHHHHHHHHHHH | 3.47 | - | |
| 83 | S-palmitoylation | CFCICKKCLFKKKNK HHHHHHHHHHHHCCC | 3.10 | - | |
| 105 | Ubiquitination | GKNAINMKDVKDLGK CCCCCCHHHHHHHHH | 55.68 | - | |
| 120 | Ubiquitination | TMKDQALKDDDAETG HHHHHHHCCCCCCCC | 63.23 | 21906983 | |
| 126 | Phosphorylation | LKDDDAETGLTDGEE HCCCCCCCCCCCCCC | 38.93 | 18510355 | |
| 129 | Phosphorylation | DDAETGLTDGEEKEE CCCCCCCCCCCCCCC | 43.21 | 22617229 | |
| 134 | Ubiquitination | GLTDGEEKEEPKEEE CCCCCCCCCCCHHHH | 64.18 | 21906983 | |
| 181 | Phosphorylation | MGGTSDPYVKVFLLP CCCCCCCCEEEEECC | 20.21 | 25884760 | |
| 202 | Phosphorylation | ETKVHRKTLNPVFNE CCHHCHHCCCHHHCC | 31.55 | 19664994 | |
| 212 | Phosphorylation | PVFNEQFTFKVPYSE HHHCCCEEEECCHHH | 23.42 | 19664994 | |
| 217 | Phosphorylation | QFTFKVPYSELGGKT CEEEECCHHHHCCEE | 20.12 | 25884760 | |
| 230 | Phosphorylation | KTLVMAVYDFDRFSK EEEEEEEEECCCCCC | 11.01 | 19060867 | |
| 237 | Acetylation | YDFDRFSKHDIIGEF EECCCCCCCCEEEEE | 42.45 | 19608861 | |
| 265 | Phosphorylation | EEWRDLQSAEKEEQE HHHHHHHHHHHHHHH | 45.77 | 24076635 | |
| 268 | Ubiquitination | RDLQSAEKEEQEKLG HHHHHHHHHHHHHHH | 67.29 | - | |
| 302 | Acetylation | LEAKNLKKMDVGGLS EEECCCCCCCCCCCC | 43.42 | 30592777 | |
| 312 | Phosphorylation | VGGLSDPYVKIHLMQ CCCCCCCHHHHEEHH | 21.26 | 25884760 | |
| 329 | Phosphorylation | KRLKKKKTTIKKNTL CCCCCCCCCCCCCCC | 42.50 | 22817900 | |
| 330 | Phosphorylation | RLKKKKTTIKKNTLN CCCCCCCCCCCCCCC | 39.41 | 22817900 | |
| 333 | Ubiquitination | KKKTTIKKNTLNPYY CCCCCCCCCCCCCCC | 51.84 | 21906983 | |
| 343 | Phosphorylation | LNPYYNESFSFEVPF CCCCCCCCCEEECCH | 23.66 | - | |
| 345 | Phosphorylation | PYYNESFSFEVPFEQ CCCCCCCEEECCHHH | 29.76 | - | |
| 365 | Phosphorylation | VVVTVLDYDKIGKND EEEEECCHHHCCCCC | 18.25 | 21082442 | |
| 381 | Phosphorylation | IGKVFVGYNSTGAEL CCEEEEECCCCCHHH | 10.71 | 28152594 | |
| 383 | Phosphorylation | KVFVGYNSTGAELRH EEEEECCCCCHHHHH | 21.53 | 28152594 | |
| 384 | Phosphorylation | VFVGYNSTGAELRHW EEEECCCCCHHHHHH | 36.45 | 28152594 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of SYT1_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SYT1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SYT1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| SV2B_HUMAN | SV2B | physical | 15466855 | |
| CF015_HUMAN | C6orf15 | physical | 15466855 | |
| SV2C_HUMAN | SV2C | physical | 15466855 | |
| STX1A_HUMAN | STX1A | physical | 9010211 | |
| HNRPQ_HUMAN | SYNCRIP | physical | 10734137 | |
| SNP25_HUMAN | SNAP25 | physical | 10692432 | |
| CAC1A_HUMAN | CACNA1A | physical | 9303303 | |
| SNP25_HUMAN | SNAP25 | physical | 12062043 | |
| STX1A_HUMAN | STX1A | physical | 10397765 | |
| FGF1_HUMAN | FGF1 | physical | 11432880 | |
| RBM14_HUMAN | RBM14 | physical | 15919756 | |
| SIN3A_HUMAN | SIN3A | physical | 15467731 | |
| SYT2_HUMAN | SYT2 | physical | 28514442 | |
| VLDLR_HUMAN | VLDLR | physical | 28514442 | |
| CWC22_HUMAN | CWC22 | physical | 28514442 | |
| EI2BG_HUMAN | EIF2B3 | physical | 28514442 | |
| EI2BE_HUMAN | EIF2B5 | physical | 28514442 | |
| EI2BD_HUMAN | EIF2B4 | physical | 28514442 | |
| PGK2_HUMAN | PGK2 | physical | 28514442 | |
| EI2BB_HUMAN | EIF2B2 | physical | 28514442 | |
| LRP2_HUMAN | LRP2 | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-237, AND MASS SPECTROMETRY. | |